Literature DB >> 15673503

Revised nomenclature of Clostridium difficile toxins and associated genes.

Maja Rupnik1, Bruno Dupuy1, Neil F Fairweather1, Dale N Gerding1, Stuart Johnson1, Ingo Just1, David M Lyerly1, Michel R Popoff1, Julian I Rood1, Abraham L Sonenshein1, Monica Thelestam1, Brendan W Wren1, Tracy D Wilkins1, Christoph von Eichel-Streiber1.   

Abstract

Several different nomenclatures have been applied to the Clostridium difficile toxins and their associated genes. This paper summarizes the new nomenclature that has been agreed to by the research groups currently active in the field. The revised nomenclature includes C. difficile toxins and other related large clostridial toxins produced by Clostridium sordellii and Clostridium novyi, and corresponding toxin genes, as well as toxin production types of C. difficile strains.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15673503     DOI： 10.1099/jmm.0.45810-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


  23 in total

1.  Production of Clostridium difficile toxin in a medium totally free of both animal and dairy proteins or digests.

Authors:  Aiqi Fang; Donald F Gerson; Arnold L Demain
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

2.  Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.

Authors:  Jason G S Ho; Antonio Greco; Maja Rupnik; Kenneth K-S Ng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 3.  Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty?

Authors:  Fred C Tenover; Ellen Jo Baron; Lance R Peterson; David H Persing
Journal:  J Mol Diagn       Date:  2011-08-18       Impact factor: 5.568

4.  Isolation of RNA polymerase from Clostridium difficile and characterization of glutamate dehydrogenase and rRNA gene promoters in vitro and in vivo.

Authors:  Nagraj Mani; Bruno Dupuy; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

5.  The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.

Authors:  Ana M Oliveira Paiva; Leen de Jong; Annemieke H Friggen; Wiep Klaas Smits; Jeroen Corver
Journal:  J Bacteriol       Date:  2020-10-22       Impact factor: 3.490

6.  Recent developments on the role of Clostridium difficile in inflammatory bowel disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

Review 7.  Clostridium difficile associated infection, diarrhea and colitis.

Authors:  Perry Hookman; Jamie S Barkin
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

Review 8.  The host immune response to Clostridium difficile infection.

Authors:  Katie Solomon
Journal:  Ther Adv Infect Dis       Date:  2013-02

9.  Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR.

Authors:  Philippe J M Bouvet; Michel R Popoff
Journal:  J Clin Microbiol       Date:  2008-10-01       Impact factor: 5.948

10.  Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.

Authors:  Ruth Murray; Dave Boyd; Paul N Levett; Michael R Mulvey; Michelle J Alfa
Journal:  BMC Infect Dis       Date:  2009-06-28       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.